We are live on
!
Find out more
Sanders Capital Portfolio holdings
AUM
$99.8B
Turnover
10.42%
1-Year Est. Return
47.9%
This Fund
S&P 500
This Quarter
Est. Return
+4.43%
1 Year Est. Return
+47.9%
3 Year Est. Return
+147.14%
5 Year Est. Return
+192.43%
10 Year Est. Return
+815.46%
AUM
$15.6B
AUM Growth
+$480M
(+3.2%)
Cap. Flow
+$247M
Cap. Flow
% of AUM
1.59%
Top 10 Holdings %
Top 10 Hldgs %
54.46%
Holding
40
New
–
Increased
25
Reduced
13
Closed
2
Avg Time Held
3.2
years
Top 10 Avg Time Held
2
years
Top 20 Avg Time Held
2.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$187M |
| 2 |
Medtronic
MDT
|
+$171M |
| 3 |
Pfizer
PFE
|
+$54.6M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$38.7M |
| 5 |
Coterra Energy
CTRA
|
+$33.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$209M |
| 2 |
D.R. Horton
DHI
|
+$77.8M |
| 3 |
Goldman Sachs
GS
|
+$66.6M |
| 4 |
Elevance Health
ELV
|
+$32.2M |
| 5 |
Prudential Financial
PRU
|
+$31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.39% |
| 2 | Technology | 23.24% |
| 3 | Financials | 15.84% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CAA
26
DELISTED
CalAtlantic Group, Inc.
CAA
| $147M | 0.95% |
4,167,200
+153,652
| +4% | +$5.58M |
2015 Q4
6 quarters
|
|
27
BP
BP
$125B
| $136M | 0.87% |
4,417,967
+781,186
| +21% | +$24.3M |
2013 Q2
16 quarters
|
|
28
Meritage Homes
MTH
$3.93B
| $134M | 0.86% |
6,365,358
-281,880
| -4% | -$5.59M |
2014 Q1
13 quarters
|
|
29
GE Aerospace
GE
$324B
| $133M | 0.86% |
1,031,216
+19,097
| +2% | +$2.62M |
2013 Q2
16 quarters
|
|
30
Stanley Black & Decker
SWK
$14B
| $113M | 0.72% |
800,648
+203,659
| +34% | +$27.9M |
2013 Q2
16 quarters
|
|
31
eBay
EBAY
$54.7B
| $98.2M | 0.63% |
2,811,600
+65,500
| +2% | +$2.24M |
2016 Q4
2 quarters
|
|
32
Genuine Parts
GPC
$18.4B
| $94.2M | 0.61% |
1,015,077
+6,038
| +0.6% | +$555K |
2013 Q2
16 quarters
|
|
33
Synchrony
SYF
$24.1B
| $79.9M | 0.51% |
2,680,323
+42,361
| +2% | +$1.26M |
2015 Q4
6 quarters
|
|
34
AbbVie
ABBV
$501B
| $45.5M | 0.29% |
627,533
+4,400
| +0.7% | +$296K |
2013 Q2
16 quarters
|
|
35
Vanguard FTSE All-World ex-US ETF
VEU
$67.4B
| $13M | 0.08% |
260,336
-3,700
| -1% | -$183K |
2013 Q2
16 quarters
|
|
36
Shinhan Financial Group
SHG
$33.5B
| $8.24M | 0.05% |
189,594
-2,500
| -1% | -$108K |
2013 Q2
16 quarters
|
|
37
Barclays
BCS
$76B
| $5.48M | 0.04% |
543,938
+1,261
| +0.2% | +$12.9K |
2013 Q2
16 quarters
|
|
38
Honda
HMC
$44.2B
| $4.45M | 0.03% |
162,481
-11,520
| -7% | -$326K |
2013 Q2
16 quarters
|
|
|
39
Goldman Sachs
GS
$260B
| – | – |
-290,214
| Closed | -$66.6M | – |
|
|
40
Prudential Financial
PRU
$40.1B
| – | – |
-290,716
| Closed | -$31M | – |
|
Similar funds
Sanders Capital's Q2 2017 Portfolio in Review
As of Q2 2017, Sanders Capital held 40 positions worth $15.6B, up 3.2% from $15.1B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Sanders Capital's Q2 2017 filing shows 25 increased, 13 reduced and 2 closed positions. The largest sale was Aptiv, an estimated $209M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- Sanders Capital added most to PepsiCo in Q2 2017, an estimated $187M increase.
- Sanders Capital's biggest Q2 2017 reduction was Aptiv, cutting an estimated $209M.
- Sanders Capital fully exited Goldman Sachs in Q2 2017, selling an estimated $66.6M.
- Sanders Capital's ten largest holdings make up 54% of its $15.6B portfolio in Q2 2017.
- Sanders Capital opened 0 new positions and closed 2 in Q2 2017.
- Sanders Capital's portfolio value rose 3.2% quarter-over-quarter to $15.6B.
Based on Sanders Capital's 13F filing for Q2 2017, filed 27 Jul 2017.